Bone Biologics Corp share price logo

Bone Biologics Corp Share Price

NASDAQ: BBLG

Small Cap

$2.12

-0.02

(-0.93%)

as on

Bone Biologics Corp Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.08
    $2.15
    downward going graph

    1.89%

    Downside

    1.42%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.95
    $16.5
    downward going graph

    8.01%

    Downside

    678.30%

    Upside

    downward going graph

Bone Biologics Corp share price movements today

Previous Close
$2.14
Open
$2.15
Volume
385.0K
Day's Low - High
$2.08 - $2.15
52 Week Low - High
$1.95 - $16.5

Bone Biologics Corp Historical Returns

1 Month Return
+ 1.44 %
3 Month Return
-60.19 %
1 Year Return
-83.09 %
3 Year Return
-99.88 %
5 Year Return
0 %

Bone Biologics Corp Stock Fundamentals & Key Indicators

Check Bone Biologics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.8M

EPS (TTM)

-4.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-825.0K

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

15109100.00%

Bone Biologics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bone Biologics Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.8MNANA0.00%
BUY$146.0B155.98%58.6313.55%
BUY$144.1B82.61%49.9812.25%
BUY$233.5B24.24%16.8332.43%
BUY$121.3B-12.46%26.1313.63%

Stock Returns calculator for Bone Biologics Corp Stock including INR - Dollar returns

The Bone Biologics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Bone Biologics Corp investment value today

Current value as on today

₹21,940

Returns

₹78,060

(-78.06%)

Returns from Bone Biologics Corp Stock

₹83,013 (-83.01%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Bone Biologics Corp Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Bone Biologics Corp. Average target price of $22.5

Bone Biologics Corp Share Price Target

Get share price movements and forecasts by analysts on Bone Biologics Corp.

What analysts predicted

90.58%UPSIDE

Target Price

$22.5

Current Price

$2.12

Analyzed by

7 Analysts

Target

$22.50

Bone Biologics Corp target price $22.5, a slight upside of 90.58% compared to current price of $2.12. According to 7 analysts rating.

Bone Biologics Corp Stock's Interest Amongst Investors

Investment in Bone Biologics Corp Shares on INDmoney has grown by 912.50% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:912.50% versus previous 30 day period

Search interest for Bone Biologics Corp Stock has increased by 1020% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1020% versus previous 30 day period

Bone Biologics Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-3
-3
-2
-1
0
0
0
-1
-1
0
EBITDA
-3
-1
-2
-1
0
0
0
-2
-1
0
Interest Expense
0
-
-
0
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-3
-1
-1
-1
0
0
0
-1
-1
0
Income Tax Expense
0
0
0
0
0
0
-
0
-
-
Net Income
-3
-1
-1
-1
0
0
0
-1
-1
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Bone Biologics Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
-
-
-
-
-
Operating Income
-11
-20
-2
-2
-2
0
-1
-3
-9
-4
EBITDA
-11
-20
-2
-2
-2
0
0
-4
0
-4
Interest Expense
1
2
4
1
0
0
0
0
2
-
Depreciation
-
-
0
0
0
-
-
-
-
-
Income Before Tax
-13
-21
-7
-4
-3
-1
-1
-1
-8
-4
Income Tax Expense
0
0
0
0
0
0
0
-2
-2
-7
Net Income
-13
-25
-7
-4
-3
-1
-1
-1
-8
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Bone Biologics Corp Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-1
-1
-1
0
0
0
-1
-1
0
Operating Cash Flow
-3
-2
-2
-1
0
0
-1
0
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
4
4
0
1
0
1
1
0
4
Change in Cash
0
-2
-1
0
0
1
0
0
3

Bone Biologics Corp Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-21
-7
-4
-3
-1
-1
-1
-8
-4
Operating Cash Flow
-7
-3
-4
-3
0
-1
-3
-9
-4
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
6
3
4
2
0
7
4
5
4
Change in Cash
0
0
0
0
0
6
0
-4
0

Global Institutional Holdings in Bone Biologics Corp

Funds
Holdings
Geode Capital Management, LLC
0.74%
Tower Research Capital LLC
0.06%
Bank of America Corp
0%
Citigroup Inc
0%
HRT FINANCIAL LLC
0%

Insights on Bone Biologics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Boston Scientific Corp. has given 19.3% return, outperforming this stock by 102.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Boston Scientific Corp. has given 136.2% return, outperforming this stock by 236.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, BBLG stock has moved down by -60.2%

About Bone Biologics Corp

a publicly-held biotechnology company that is a spin off of the musculoskeletal transplant foundation (mtf) using technology discovered and licensed from ucla. bone biologics market and focus is in the regenerative medicine orthobiologics space. bone biologics was founded in 2004 by university of california professors in collaboration with an osaka university professor and a usc surgeon and acquired in 2006 by mtf as the major shareholder, who has been the primary funder since the acquisition. the company’s proprietary, patented platform technology ucb-1™, exclusively licensed from ucla, has met and surpassed existing standards of care outcomes in completed large animal model (sheep and rhesus monkey) studies that have demonstrated that the ucb-1™ technology facilitates superior normal bone growth. the company believes that as a platform technology, ucb-1™ has broad applications in delivering improved outcomes in almost all surgical procedures involved in bone repair and regeneration.
OrganisationBone Biologics Corp
Headquarters2 Burlington Woods Drive, Burlington, MA, United States, 01803
IndustryBiotechnology
CEOMr. Jeffrey Frelick
E-voting on sharesClick here to vote

Key Management of Bone Biologics Corp

Name

Title

Mr. Jeffrey Frelick

CEO & President

Ms. Deina H. Walsh CPA

Chief Financial Officer

FAQs

What is Bone Biologics Corp share price today?

Bone Biologics Corp share price today is $2.12 as on at the close of the market. Bone Biologics Corp share today touched a day high of $2.15 and a low of $2.08.

What is the 52 week high and 52 week low for Bone Biologics Corp share?

Bone Biologics Corp share touched a 52 week high of $16.5 on and a 52 week low of $1.95 on . Bone Biologics Corp stock price today i.e. is closed at $2.12,which is 87.15% down from its 52 week high and 8.71% up from its 52 week low.

What is Bone Biologics Corp's market capitalisation today?

Bone Biologics Corp market capitalisation is $0.00T as on .

How to invest in Bone Biologics Corp Stock (BBLG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bone Biologics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bone Biologics Corp Shares that will get you 0.7075 shares as per Bone Biologics Corp share price of $2.12 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bone Biologics Corp Stock (BBLG) from India?

Indian investors can start investing in Bone Biologics Corp (BBLG) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Bone Biologics Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Bone Biologics Corp share’s latest price of $2.12 as on September 18, 2025 at 1:29 am IST, you will get 4.7170 shares of Bone Biologics Corp. Learn more about fractional shares .